Honey vs. steroids: can a sweet paste soothe chronic mouth pain?
NCT ID NCT06988527
First seen Jun 26, 2026 · Last updated Aug 28, 2026 · Updated 3 times
Summary
This study tests a honey-based paste against a standard steroid ointment for treating painful mouth sores caused by oral lichen planus. Fifty-six adults with erosive or atrophic lichen planus will use the paste daily for four months. Researchers will track symptom improvement, pain levels, and quality of life to see if honey can be a gentler alternative.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- honey in orabase (1:1) paste
- What this could lead to
- If it works, this could offer a natural, low-cost alternative to steroid treatment for managing oral lichen planus symptoms.
- What could go wrong
- This is a small, early-phase study (56 participants) comparing honey to a standard steroid. Honey may not be as effective, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 2
Tests whether the treatment actually works, and watches for side effects, in a larger group.
- Participants
-
56 people
The number who actually took part.
- Started
-
May 2025
- Finished
-
Jun 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
35 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients with a clinical diagnosis of oral lichen planus * Symptomatic OLP lesions (erosive/atrophic) * Participants are between 35 and 60 years old, who are able to adhere to the study protocol, and sign informed consent. Exclusion Criteria: * Patients with other oral mucosal disorders, or systemic conditions influencing OLP or wound healing, allergies or hypersensitivity to honey or triamcinolone * Patients who administer systemic corticosteroids or immunosuppressive agents. * Pregnancy or lactation * Inability to comprehend or adhere to study directives * Patients who are not able to sign an informed written consent
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Atrophic lichen planus are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dar AlUloom University
Riyadh, 11512, Saudi Arabia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a glowing light reveal hidden mouth lesions?
- Aloe vera vs. steroid: which tames oral lichen planus?
- Can a common steroid gel quiet oral lichen planus by altering MicroRNAs?
- A pharmacist in the dentist's chair: could a new team approach tame stubborn mouth conditions?
- New oral spray aims to ease sore throat and canker sores without drugs
- Gum disease link in mouth condition under investigation